Literature DB >> 7399676

Fibril-mediated adherence of Actinomyces viscosus to saliva-treated hydroxyapatite.

T T Wheeler, W B Clark.   

Abstract

Fibril-mediated adherence of Actinomyces viscosus strain T14V cells to saliva-treated hydroxyapatite was studied. Fibrils were purified by ammonium sulfate precipitation and differential centrifugation from the crude supernatant of whole cells that were sheared by one passage through a French pressure cell. Purified fibrils and crude supernatant inhibited strain T14V adherence to saliva-treated hydroxyapatite to similar extents. However, anti-strain T14V serum and antifibril specific antibody completely abolished strain T14V adherence. The blocking immunoglobulin could be adsorbed from anti-T14V serum by strain T14V whole cells, by purified fibrils, and, to a lesser extent, by cell walls. It was concluded that fibrils mediate adherence of strain T14V cells to saliva-treated hydroxyapatite. In addition, fibril preparations were shown to contain more than 95% protein and to be antigenically homogeneous by immunodiffusion and Laurell rocket immunoelectrophoresis. Purified fibril preparations showed serological identity with the virulence-associated 1 antigen of Lancefield-extracted T14V cells, whereas crude supernatants contained both virulence-associated 1 and virulence-associated 2 antigens, as shown by rocket immunoelectrophoresis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7399676      PMCID: PMC550973          DOI: 10.1128/iai.28.2.577-584.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

Review 1.  The structure, function, synthesis and genetic control of bacterial pili and a molecular model for DNA and RNA transport in gram negative bacteria.

Authors:  C C Brinton
Journal:  Trans N Y Acad Sci       Date:  1965-06

2.  Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads.

Authors:  P Cuatrecasas
Journal:  J Biol Chem       Date:  1970-06       Impact factor: 5.157

3.  Chemical fixation of enzymes to cyanogen halide activated polysaccharide carriers.

Authors:  R Axén; S Ernback
Journal:  Eur J Biochem       Date:  1971-02-01

4.  Plaque formation and periodontal pathology in gnotobiotic rats infected with an oral actinomycete.

Authors:  H V Jordan; R J Fitzgerald; H R Stanley
Journal:  Am J Pathol       Date:  1965-12       Impact factor: 4.307

5.  Characteristics of some high molecular weight constituents with bacterial aggregating activity from whole saliva and dental plaque.

Authors:  D I Hay; R J Gibbons; D M Spinell
Journal:  Caries Res       Date:  1971       Impact factor: 4.056

6.  Immunochemical identification of specific precipitin lines in quantitative immunoelectrophoresis patterns.

Authors:  J Kröll
Journal:  Scand J Clin Lab Invest       Date:  1969-08       Impact factor: 1.713

7.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

8.  Chemical properties of the pili of Corynebacterium renale.

Authors:  N Kumazawa; R Yanagawa
Journal:  Infect Immun       Date:  1972-01       Impact factor: 3.441

9.  M protein-associated adherence of Streptococcus pyogenes to epithelial surfaces: prerequisite for virulence.

Authors:  R P Ellen; R J Gibbons
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

10.  Studies on gonococcus infection. IV. Pili: their role in attachment of gonococci to tissue culture cells.

Authors:  J Swanson
Journal:  J Exp Med       Date:  1973-03-01       Impact factor: 14.307

View more
  28 in total

1.  Mutants of Actinomyces viscosus T14V lacking type 1, type 2, or both types of fimbriae.

Authors:  J O Cisar; A E Vatter; W B Clark; S H Curl; S Hurst-Calderone; A L Sandberg
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

2.  Expression of Actinomyces viscosus antigens in Escherichia coli: cloning of a structural gene (fimA) for type 2 fimbriae.

Authors:  J A Donkersloot; J O Cisar; M E Wax; R J Harr; B M Chassy
Journal:  J Bacteriol       Date:  1985-06       Impact factor: 3.490

3.  Antibodies that bind to fimbriae block adhesion of Streptococcus sanguis to saliva-coated hydroxyapatite.

Authors:  S Fachon-Kalweit; B L Elder; P Fives-Taylor
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

4.  Antibodies against the Ag2 fimbriae of Actinomyces viscosus T14V inhibit lactose-sensitive bacterial adherence.

Authors:  G J Revis; A E Vatter; A J Crowle; J O Cisar
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

5.  Identification of a Streptococcus salivarius cell wall component mediating coaggregation with Veillonella alcalescens V1.

Authors:  A H Weerkamp; B C McBride
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

6.  Regulation of extracellular slime production by Actinomyces viscosus.

Authors:  T Ooshima; H K Kuramitsu
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

7.  Identification and preliminary characterization of a Streptococcus sanguis fibrillar glycoprotein.

Authors:  E J Morris; N Ganeshkumar; M Song; B C McBride
Journal:  J Bacteriol       Date:  1987-01       Impact factor: 3.490

8.  Relative hydrophobicities of Actinomyces viscosus and Actinomyces naeslundii strains and their adsorption to saliva-treated hydroxyapatite.

Authors:  W B Clark; M D Lane; J E Beem; S L Bragg; T T Wheeler
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

9.  Adherence of oral streptococci: evidence for nonspecific adsorption to saliva-coated hydroxylapatite surfaces.

Authors:  R H Staat; J C Peyton
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

10.  Specific inhibition of adsorption of Actinomyces viscosus T14V to saliva-treated hydroxyapatite by antibody against type 1 fimbriae.

Authors:  W B Clark; T T Wheeler; J O Cisar
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.